Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hybrid Model of Tertiary and Community Delivery of Hepatic Artery Infusion Chemotherapy
NCT07201519Phase 2Recruiting
- Start
- Jan 2026
- Primary completion
- Feb 2028
- Countries
- 1
01
Overview
Phase 2, open-label trial in colorectal cancer (CRC) and intrahepatic cholangiocarcinoma (ICC) (2 cohorts). Primary endpoint: Percent of participants with HAI Pump still in use at 3 months. Started Jan 2026; status: recruiting.
02
Conditions
colorectal cancer (CRC)intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT07201519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07201519.